Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections

Details for Australian Patent Application No. 2004270102 (hide)

Owner Pestka Biomedical Laboratories, Inc.

Inventors Pestka, Sidney; Clark, William A.; Lavoie, Thomas B.

Agent Shelston IP

Pub. Number AU-B-2004270102

PCT Pub. Number WO2005/023290

Priority 60/473,134 23.05.03 US

Filing date 21 May 2004

Wipo publication date 17 March 2005

Acceptance publication date 1 October 2009

International Classifications

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/22 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2005/023290 Priority application(s): WO2005/023290

1 October 2009 Application Accepted

  Published as AU-B-2004270102

28 January 2010 Standard Patent Sealed

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270103-Human monoclonal antibodies against Bacillusanthracis protective antigen

2004270101-Delivery of physiologixal agents with insitu gels comprising anionic polysaccharides